Copyright 2024 All rights reserved.
Customers
Development of safe stem cell therapy for
immune rejection
We are working to improve
the quality of life in various fields.
Customer
Newsroom
STEMMEDICARE has received approval for translational clinical research in Japan.
194
The exosome treatment developed by STEMMEDICARE has been approved for translational clinical research in Japan.
For more information, see the article link below.
국내 바이오산업 메카 오송 '글로벌 혁신특구' 후보지로 주목 - 충북과 나의 연결고리 충북일보 (inews365.com)